text:
Thursday, November 15, 2012
To Paint or Not To Paint?...That Is The Question
40 comments:
I say go for it! I love the look of a painted piano!ReplyDelete
Paint with milk paint or chalk paint and distress it to reveal chippy heaven!ReplyDelete
I say Paint It! It will look awesome!ReplyDelete
Man...what a HUGE question!! I think it would look awesome painted, but I wonder..ReplyDelete
Do you have the front panel? Would the white look okay without that panel?
Try taping over the wood with cheap white tissue paper and see if you like the look first...
Then..GO FOR IT! Or not..!!:)
Take a deep breath and just go for it! It will look amazing!ReplyDelete
Definitely go for it!ReplyDelete
I vote yes! It's so easy making decisions for somebody else. Why can't I decide to paint or not to paint my own things?!ReplyDelete
Absolutely paint it, if you don't you will always wonder 'what if'.ReplyDelete
Follow your inspiration, always! That piano is a great find. I can't wait to see it painted. You know you want to ; )ReplyDelete
Sure, I'd also paint it white from the outside! I love white pianos!ReplyDelete
I think it would look great painted! I think milk paint might be a good idea. (though I have never used it so I really don't know what I'm talking about) :)ReplyDelete
That´s a difficult question to answer ;).ReplyDelete
I can´t always make up my mind my self.
I love the white piano but on the other hand the worn and chipped version is also nice ;)
Have a great day.
Huggs, Erica
I would try with milk paint without bonding agent, so the paint can chip away.ReplyDelete
Paint it! Your accents will stand out so much better on a painted piano; in fact, why not get all crazy and paint it...turquoise or another amazing color!ReplyDelete
You know I'm all about paint, but I would take a different route in this situation. I like it the way the piano looks as is. The open top against your vintage wall covering is a great combo, but you have a lot of different wood tones going on around it. While looking at your picture, if you take your left finger and cover up the chair rail and your right hand and cover up the door, it totally changes the look. A dark walnut stain would look great on the chair rail(of course that would be an entire house project, but it would really look cool against your vintage sheets). I would paint the door and trim around it in a color most similar to the off-white in the papers to make it go away, that way your piano becomes more of a focal point. In your spare time ~ aren't you glad you asked?ReplyDelete
I feel it would look great painted. Nancy CarrReplyDelete
I love white piano at Miss Gracie's blog.ReplyDelete
Just say "NO"! I really believe that some of the beauty of the wood and the craftsman's ability to match veneers are what make these old pieces so lovely. That looks like "Tiger Oak" on your piano. I remember reading something about the trees that produce this beautiful grain not being grown anymore. I also see that it brings warmth to your decor. Too much white seems so chilling. Just love the look of the wood in combination with your awesome wall.ReplyDelete
Yep, and I'd go for the second photo look. Stunning!! So my vote is YES. :-)ReplyDelete
Oh come on Angie...you know it would look so great painted! Go for it!ReplyDelete
Sometimes it's hard for me to type such words, but I too say....... paint it.ReplyDelete
Oh my!!! I have a panel from a piano like the piece you are mssng on yours. After seeing this, I now HAVE to paint it! Paint yours too! Those pictures rock!ReplyDelete
It's beautiful but I would paint it. I don't think it would loose any of it's charm
I like the objects to remain just manufactured ...ReplyDelete
But ... a big but ... Ι vote yes !!!!
It's a YES vote from me!ReplyDelete
Oh, sure, go for it...wish I could paint mine...(mine isn't that old)ReplyDelete
How about the ASCP in country gray? or French Linen?? Those are great colors!
As someone who lived with a dark wood piano for years, I have to say PAINT IT!!!!!ReplyDelete
I think I agree with the majority to paint it. It is beautiful but I think painting it would give it a new personality in your room. I am all about old history treasures re invented into your home so go for it.ReplyDelete
I vote yes to paint it white, can't wait to see it transformed!ReplyDelete
Have a great weekend!
XXX Ido
I'm a gal that does not easily paint old pieces, but this piano could look fabulous with some paint.ReplyDelete
Farmhouse hugs,
To paint for sure:)ReplyDelete
hi Angie ... I love old wood, but I think I would like this painted ... color of your choice.ReplyDelete
Audrey Z. http:/
Timeless Treasures /audreyzumwalt.blogspot.com/
I think the white painted piano in the picture is pretty, but I think paint in the case of your piano would be a detriment. The contrast in colors of the woods and the exposed "bones" of the piano make it really interesting as it is. I think paint would definitely detract from the interesting things already going on with it.ReplyDelete
I saw one in a blog yesterday that was beautiful turquoise ! But if I had one, I think I'd have trouble painting it, too.ReplyDelete
Paint it....!!! I am in the process of lightening all of my furniture/house etc. I have a hard time dealing with winter where I live. It is pitch dark outside by 5:00 in the heart of winter. I need the inside to be light!!! It will be done as soon as we get our store done. (There is always a project!!!)ReplyDelete
Paint! For sure...paint it!ReplyDelete
Paint it! The wood doesn't look special, just dull and brown. I saw a yellow one recently that was sweet. xReplyDelete
Definitely paint it! It would look fabulous in white! Can't wait to see it!ReplyDelete
I say paint it!!ReplyDelete


text:
My Account
0 item(s)
Total: $0
view cart
Follow Us
Walk the Candy Aisle
Candy by Types
Candy by Decades
Candy by Occasions
Decade Boxes
Party Favors
Retro Toys
What's New
Reward Points
What's This?
1 points will be rewarded to you when you buy this item.
Whoppers - 5 oz theater box
In Stock
Whoppers are chocolate-coated malted milk balls made by The Hershey Company. The candy is a small, round ball about 3/4 of an inch in diameter.
Whoppers Malted Milk Balls: more choices >>>
Orders placed by midnight usually ship on the next business day.
Your Price:
Write a Review
Add to Wish List
Tell A Friend
Do you have a favorite
"candy you ate as a kid"
Share it here.
I was 10 years old in 1956 and I remember being addicted to whoppers. I used to help my Dad count his money and one day he had a lot (maybe 30) of one dollar bills. When he wasn't looking, I stole $1.00. The first thing I did was go to the store and buy as many whoppers as I could get for my (stolen) dollar.
Later that night Dad told me that he had (lost) one of his dollars and because of that....he couldn't pay the electric bill that week. I started crying and told him what I did. Naturally he forgave me... and also taught me a valuable lesson. If I wanted whoppers... I had to work for them. THAT'S when I started to clean the house and make my own money. Almost ALL of it went for whoppers. I still love whoppers and now I buy them by the box. ~ Michele from Pennsylvania
Average Rating
Sweet Tooth
Whoppers were a favourite candy of mine as a kid and that has not changed. These are delicious!
Reviewed by:
Isobel Bilyk
from Canada.
on 5/30/2011
Tell A Friend
Recently Viewed Items
Customer Service
Contact Us
Download Price List
Reward Program
Terms & Conditions
Corporate Gifts
Hot Weather
APO / FPO orders
Track Your Order
About Us
Our History
Mission Statement
Why buy From US?
Water Wells for Africa
Safe Shopping
100% Satisfaction
Better Business Bureau
Privacy Policy
PCI Compliance
Discontinued Candy
Affiliate Programs
Candy Blog
Email Newsletter
Click to verify
© 2000 - 2014 by the Old Time Candy Company All rights reserved.
350 Commerce Drive East | LaGrange, OH 44050 | 1-440-355-4345
Candy you ate as kid®
is a registered trademark of the Old Time Candy Company
Have a question or comment?
Contact Us
To God be the glory, great things He has done!
Questions? Feedback?
powered by
Olark live chat software

subset: commoncrawl


text:
Your search "lomo lca america travel fun chill" resulted in translation missing: en, common, article
Are you new to Lomography?
This week's popular entries
Film Manipulation: Mixing Bleach, Detergent and Negatives I've been experimenting with many substances, more or less corrosives, for film manipulation. The images come out so different, that sometimes you can't even recognize them. The pictures in this experiment are a result of mixing bleach and detergent powder.
Show Your Stash, gepo1303! Welcome back to another edition of Show Your Stash! For this week, let's check out gepo1303's stash during his trip to Iceland.
Win Some Super Treats with Candy Kittens! Lomography is excited to announce a brand new Rumble with super cool confectionery company Candy Kittens. Grab the chance to win a Gourmet Gummy Gift Pack full of chewy sweet treats and a t-shirt too. Find out more about this competition after the jump.
More of this weeks popular entries
- Strut Your Summer Style Rumble Winners Announcement
- radoslav is our LomoHome of the Day!
- Awesome Albums: Hats & Masks by clownshoes
- Photo of the Day by neja
- Photo of the Day by mafiosa
- Most Popular Photo Last Year: July 24, 2013
- Most Popular Photo Last Year: July 22, 2013
- My Pinolga Camera: A Pinhole Camera Made of Cardboard and Looks Like the Holga
- Fresh from the Lab: Shooting London at Dawn with Fuji Provia 100
- LomoGuru of the Week: stonerfairy
Latest Shop News
What is happening today
- Guess That Tag! Rumble: The Analogue Diver ends in about 13 hours
Ongoing competitions
- Guess That Tag! Rumble: The Analogue Diver ends in about 13 hours
- LibTech Rumble: Surf's Up! ends in 3 days
- Search for the Mad Analogue Scientist: Show Us Your Film Experiments ends in 3 days
- The Director's LomoKino Showreel: Team Spirit ends in 4 days
- Show Us Your Flower Beard! ends in 4 days
- The Petzval Apprentice Competition ends in 6 days
- The Comment Your Caption Rumble: In Black and White ends in 8 days
- The Lomography Hipshot Showdown: Close and Clear ends in 11 days
- Win Some Super Treats with Candy Kittens! ends in 16 days
- Lomography Holiday Challenge 2014 ends in 3 months
What events are up next?
- UK Workshops and Events: August starts in 3 days


text:
By Sarah Plummer
Register-Herald Reporter
After a national search, New River Community and Technical College has named Dr. L. Marshall Washington its third president.
Washington was recommended by the New River Board of Governors during their Feb. 7 meeting and was then approved Wednesday by the West Virginia Council for Community and Technical College Education.
He will begin his new duties on March 25.
"It is my pleasure to announce that the Board of Governors unanimously approved the appointment of Dr. Washington." said Leslie Baker, chair of the NRCTC Board of Governors.
"The presidential search began last November. The college was fortunate to have a dedicated committee comprised of board members, faculty, student and staff representatives and community members. Everyone brought a different perspective, but all came to focus on the singular goal of selecting a president who could lead New River as we begin our pivotal second decade as an institution."
Baker noted that the board found Washington to have the integrity, experience and vision necessary to carry New River into a new age.
Washington said he is very excited about coming to New River and representing the college throughout its service area.
"I readily identify with the community and have a vision for how we can work together to advance higher education across the region," he said.
The new president said his first order of business will be to talk to people throughout the nine counties to find out as much as possible about how the college can best serve its stakeholders.
"I will be doing a lot of listening and learning," he said.
During the question and answer session as part of Washington's multi-campus tour on Jan. 24, staff and administrators made it clear they were searching for a candidate who can raise the funds needed to move forward on New River's central campus project in Beaver.
Washington and his wife of almost 20 years, Tonja, have a family connection to the Beckley area. His mother grew up in the Kanawha County community of Sharon and he is looking forward to reconnecting with extended family throughout the area.
Most recently Washington has served as the vice president of the Lancaster Campus of Harrisburg Area Community College in Pennsylvania.
He previously served as vice president of student services at Kellogg Community College in Michigan. He earned a doctorate in educational studies with a specialization in educational leadership and higher education from the University of Nebraska-Lincoln; a master's degree in education from Winona State University in Minnesota; and a bachelor's degree in elementary education from Ohio Wesleyan University in Delaware, Ohio.
Washington replaces Dr. Ted D. Spring, who left New River last November to become president of Cape Fear Community College in Wilmington, N.C.
Dr. Merle Dempsey is serving as interim president and will stay on until early April to assist in the transition period.
New River Community and Technical College has campuses in Beckley, Lewisburg, Ghent, Princeton and Summersville.
— E-mail: firstname.lastname@example.com


text:
Idle speculations that I haven't seen yet: Vanna spent two turns juice on the (*ptui*) Kingworld spell. All signs point to it being a tri-mancer link, even though we have not seen the third caster. "Two turns" makes me think Dittomancer. All I have to say on the matter is that it had best be a tri-mancer link. If Charlie can end another sides turn simply by hiring a Turnamancer from the MK, then my opinion of this web comic will be very low. There should be more cost than that, as well. I just hope that when the details are revealed, and they must be for reader satisfaction, that they make some sort of sense. Not like the last time we were promised that all would be made clear and what we got was the craptastic "Charlie didn't offer this strategy, but Ansom knew to ask."
Hate to rehash this, but the signs point to no such thing. Vanna said "Charlie released me" if she had been in the intimate coils of a tri-caster link she would have said "'Charlie released US" - we've seen casters in a TCL have problems unravelling whose mind is whose afterwards. We know a thinkamancer can enhance another caster's ability, Charlie as the attuned thinkamancer has almost infinite power do so (if he chose to use it) and therefore could link with Vanna and boost her abilities immeasurably. The juice she consumed would be in containing the power channeled through her. All of these all plausible within the established paradigm QED.


text:
This recent editorial from the Statesman Journal deserves a bit of a fisking:
- Way back in 1973, a bunch of Oregonians got together with a common goal: save farmland and stop urban sprawl.
They came from different parts of the state, different occupations and different political parties. But they shared a common understanding: The environment of this state is what shapes us as Oregonians.
These visionary individuals created Senate Bill 100, the most effective and resilient land-use program in the United States. The program's No. 1 goal was citizen involvement, and thousands of Oregonians helped cities, counties and the state design and implement the land-use rules.
Minor quibble, but was the goal to save farmland and stop sprawl, or citizen involvement? I'd argue the former, but give the Statesman Journal credit for trying to pull as many heartstrings as possible. They're laying it on so thick that you can almost touch S.B. 100's noble intentions.
- For all the good that law did, it never escaped its persistent foes. Legislature after Legislature fended off attempts to emasculate the land-use program. Last fall, it was the people who surrendered.
I guess that one man's "surrender" is another man's stand for protecting private property rights.
- By a stunningly wide margin, Oregonians embraced Measure 37 and jilted decades of consistent land-use planning. The measure places local and state governments in a bind: Either allow many property owners to do whatever they wish with their land or pay them not to.
Outright deception here...M37 doesn't allow property owners to do "whatever they wish;" it allows them some reprieve when regulations not in existence at the time of purchase are subsequently adopted that decrease the value of the property. Only in the social engineer's mind does that equal a free-for-all.
- Oregonians' approval of Measure 37 did more than chop local land-use ordinances into pieces. The measure stunned the nation, stalling efforts elsewhere to rein in sprawl.
Dramatic hyperbole, anyone? Read this recent Washington Policy Center analysis of M37 implementation, which argues that it hasn't produced anywhere near the catastrophe that detractors have claimed.
And how exactly did M37 stall anti-sprawl efforts elsewhere? Unless M37 somehow placed handcuffs on the planning profession nationally (and it didn't), then the anti-sprawl train is still chugging forward.
- This background illustrates why one of the 2005 Legislature's most important acts was the establishment of a task force. Ten people will conduct the first comprehensive, objective view of the land-use system since it was created 32 years ago. Before court cases and civic inaction destroy the land-use program, the task force must recommend how to restructure it and make it relevant to contemporary life.
Finally, some sanity. It's about time that someone stepped back and took a look at Oregon's dinosaur planning system. Let's hope that this task force does not just become an echo chamber designed to tinker around the edges.
- Democratic Gov. Ted Kulongoski pushed for review. Like the legendary Republican Tom McCall, Kulongoski is equally at home in the small towns and deserts of Eastern Oregon and the urban centers and coastal towns of Western Oregon.
Working with Republicans and Democrats, McCall prodded the 1973 Legislature into protecting both the environment and the economy. In his opening address to that Legislature, McCall said, "There is a shameless threat to our environment and to the whole quality of life, an unfettered despoiling of the land. Sagebrush subdivisions, coastal 'condomania,' and the ravenous rampage of suburbia in the Willamette Valley all threaten to mock Oregon's status as the environmental model for the nation. We are dismayed that we have not stopped misuse of the land, our most valuable finite natural resource."
Over time, that model land-use program became mired in regulations. Rank-and-file Oregonians lost touch with it, except when it blocked the sale or development of their property. Seemingly thoughtful regulations wound up allowing development on some prime farmland instead of steering housing to low-value hillsides.
You mean good intentions don't automatically lead to good policy outcomes? Could this actually be an acknowledgement that the planning system has become a bloated, over-regulatory bureacratic structure unresponsive to citizens and a vehicle for massive social engineering?
- Despite the program's many imperfections, Oregon was more successful than any other state in containing sprawl and maintaining farmland. Because of land-use regulations, commute times are shorter than in many regions and the air quality is better. In the Portland area, an unusually high percentage of residents are able to walk, bicycle or take public transit to work. Almost every Oregonian is only minutes away from a beautiful, restful rural setting. And according to one survey after another, Oregon has retained a national reputation for being hospitable to businesses.
Well, that's certainly one rosy view. But here's a counter.
- Yet Oregonians agree less and less on what constitutes responsible, reasonable land-use regulation. Disputes range from the location of Abiqua School and Court Street Christian Church in the Salem area to the placement of Wal-Marts in Southern Oregon.
The dilemma is that Oregonians profess love for the land and the water but also respect personal rights.
Back in 1973, Oregonians didn't always agree, but they shared more of a common ground. The new task force is a critical step in helping us find that ground again.
Hopefully this is correct. Oregonians are obviously displeased with a planning system that has grown increasingly unwieldy, so a return to the drawing board wouldn't be a bad idea. But don't underestimate the resistance among true believers...Oregon's planning is the holy grail for most urban planners, the standard by which all others are judged, so don't think that they'll let it be tweaked without a fight.
One last thought...I think it's useful to recall the recent words of Richard Carson, former Portland Metro head, about Measure 37:
- Certainly there is a lot of hand wringing and wailing by Oregon planners these days. But the one thing you won't hear is anyone acknowledging that planning caused this revolt. Indeed, in typical response, the planning profession simply says, "The voters just didn't understand. If only we could have explained it to them." I have been a professional planner for over 25 years and I hear that refrain a lot.
Why is it is never a failure on our part as planners to understand what citizens really want? Why is it always a failure on the citizens' part to understand what a wonderful gift we are giving them? Do we not understand that we are guilty of the sin of pride and the ballot measure was the price of our prejudice? Why do we continue to believe that the voters aren't capable of making intelligent decisions?
As a professional planner of almost 30 years, I am ready to say "mea culpa." But then I have written numerous essays that foreshadowed this day. I have railed against the sins of centralized planning, social engineering and faux citizen involvement. This is especially true about the grand Oregon "experiment" that in time became institutionalized into a monolithic and unresponsive planning bureaucracy.


text:
Staff report
Glasgow Daily Times
The Barren County High School Trojans used a three-run fifth inning recently to help them take a big 3-1 victory on the road at Franklin-Simpson.
Both teams opened the game with solid defense as neither team could generate much offensive power.
The game was scoreless until the top of the fifth inning when the Trojans plated three.
With one out, Cole Payne singled and Derek Gossett reached on a walk. Barrett Billingsley followed that with a walk to load the bases for the Trojans.
Alex Puleo came up and he also reached on a walk that forced in Payne. Josh Owen followed Puleo with a single to right field to score Gossett and Billingsley to give Barren County a 3-0 lead.
Read more of this story in the print or e-Edition of Monday's Glasgow Daily Times.


text:
The Mankato Free Press
---- — When it comes to the idea of regional sports complex in Mankato, respondents to our online poll are crying foul.
Our question was: Local governments are seriously considering coming together to build a sports complex. Do you think a sports complex will add to our regional appeal?
A solid majority — 53 percent, 72 votes — went with this answer: "No. We should have better priorities than sports all the time."
But it wasn't a complete blowout. About 39 percent (53 votes) went with the affirmative answer: "Yes. Sports is big tourism draw, which brings money into our community. A complex like this can be a boon for the Mankato area."
Just a handful went with this answer: "I'd be OK with this idea if they put the same effort into researching ways the arts can contribute to our community's appeal."
Comments at our Facebook page included:
• Brock Allore: "I'm all for it. Caswell already is busy every weekend and more diverse facilities could attract a lot of high school, colllege and even national competition."
• Tony Hanson: "Absolutely not! How about repairing horrible roads first! And no more stupid roundabouts! How about local governments coming together to encourage better business growth in the area to create better paying jobs?"
The Free Press online poll is not scientific. Visit mankatofreepress.com to weigh in on our latest question: The gay marriage bill looks like it will become law. Are you confident the will of a majority of Minnesotans has prevailed?


text:
Scott Vanderberg
Title: Equipment and Facilities Manager
Office: 161 LSH
Phone: 616-331-3105
Email: firstname.lastname@example.com
Scott Vanderberg has been a staff member in the School of Communications at GVSU for nearly 25 years, teaching film, video and broadcasting classes for the past 20 years. Vanderberg has been involved with Grand Valley's Summer Film Projects since 1992, and has served as Director of Photography on four of the films. As Facilities Manager for the School of Communications, Vanderberg oversees all of the departmental field production equipment and post-production suites.
Broadcasting, Lighting for Film & Video Production.


text:
Getty Images
LOS ANGELES, CA - OCTOBER 18: Director Jon Favreau onstage as he wins Best Science Fiction Movie, during Spike TV's 2008 Scream awards held at the Greek Theater on October 18, 2008 in Los Angeles, California. (Photo by Frederick M. Brown/Getty Images)
"The Avengers" movie will have to assemble without Jon Favreau.
The "Iron Man" and "Iron Man 2" director, who had been rumored to take the helm for the Marvel super-team's big screen 2012 debut, "will not be available" for the job, he told MTV News.
VIEW THE PHOTOS: First Look: 'Iron Man 2'
"They'll have to [find a different director]," he said, explaining that he'd still be involved. "It's something I'm being the executive producer on, so I'll definitely have input and a say."
The film will be preceded by three other Marvel movies – "Iron Man 2," "Captain America" and "Thor," all of which will set the stage for the super-team.
VIEW THE PHOTOS: Spectacular Superheroes
"We want to reinforce a lot of the stuff we started to tip off," Jon said. "'The Avengers' is a much larger concern for Marvel and Kevin Feige, who runs Marvel. They're going to be doing 'Thor' and 'Captain America,' and the way we might start to tease those things in ['Iron Man 2'], some of it is stuff that we've discussed [and] some of the stuff you do last-minute as you figure out how that stuff is coming together."
He's hoping the details will stay top-secret – though as he discovered with "Iron Man" and its secret Nick Fury (Samuel L. Jackson) cameo, it's difficult to keep things off the Internet for long.
"It's an evolving, amorphous thing. If we decide and commit too early, the secret always gets out," he said. ""As soon as we shot the Nick Fury thing — we had a closed set and nobody was supposed to know about it — week later somehow it was all over the internet. It's a little bit of a cat-and-mouse game."
VIEW THE PHOTOS: Robert Downey Jr.
"Iron Man 2" is due in theaters on May 7, 2010.
Related Content from AccessHollywood.com:
PLAY IT NOW: Comic-Con 2009: Jon Favreau Talks 'Iron Man 2'
PLAY IT NOW: Comic-Con 2009: Robert Downey Jr. Talks 'Iron Man 2'
MORE ACCESS ON THESE TOPICS: Jon Favreau - Iron Man - Marvel - Samuel L. Jackson - Movies


text:
We have a tremendous response to registration for Parent-Daughter Engineering Day. Registration for both days are now closed. If you are looking for a similar event in the community, the University of Utah's Society of Women Engineers will host, Girl Scout Day 2014, in late February. This annual event is for girls in grades 4-12. The theme will be "Edible Engineering".
Find more information at Girl Scout Day 2014.
For information on other events please check out our outreach calendar at:
http://weber.edu/COAST/Outreach.html for future events.


text:
Cleveland State University NCAA News
Cleveland State University Sports news continually updated from thousands of sources around the net.
Jun 16, 2014 | The Chronicle-Telegram
Elyria High and CSU softball star Woodard to face nation's best tonight
Former Elyria High and current Cleveland State softball player Cynthia Woodard will take the field tonight with the best players in the United States.
Popular Stories
Michigan State basketball adds Cleveland State transfer Bryn Forbes
The Michigan State men's basketball program added its second transfer this week when Cleveland State's Bryn Forbes, a Lansing native, confirmed Friday he was joining the Spartans.
Sports Briefs: Three former Vikings win club lacrosse title, plus fencing news
UNC Chapel Hill's women's club lacrosse team won the 2014 US Lacrosse Women's Collegiate Lacrosse Associates Division II National Championship on May 10. Three former Hoggard High School players - Sarah McCullough, Grace Marquino, and Ali Valinski are members of the team and reportedly all three have been made significant contributions to the ... (more)
Cleveland State's Bryn Forbes given permission to talk with Michigan State about possible transfer
Personal issues at home, where the Vikings leading scorer has a son, along with medical issues with his sister, led Forbes to ask CSU officials to speak with the Spartans.
Updated: Mon Jun 16, 2014 11:55 pm
Copyright © 2014 Topix LLC


text:
Hopefully he has done his part to remain at something close to playing shape and won't embarass himself or the team in August.
The Journal Sentinel's team of Packers beat writers provide the latest news, notes and analysis
Packers reduce DE Johnny Jolly's salary to $715,000
The Packers have reduced the salary of DE Johnny Jolly from $2.521 million to $715,000, saving them approximately $1.8 million of cap space.
That leaves the team at roughly $17.9 million heading into the start of free agency.
Jolly had received the first-round restricted free agent tender of $2.521 million before he was suspended for violating the substance abuse program. When he was reinstated his salary went back on the books.
Given his history, the Packers weren't going to pay a lot of money to give Jolly another shot, so they made a deal with his agent to knock his salary down to $715,000. There is a $383,000 split, which occurs if he winds up on injured reserve.
It's not clear that the Packers have made a decision to give Jolly another chance. They may just be keeping their rights to him until they have a chance to talk to him and work him out. It's not known if that has already happened or will happen in the near future.
Either way, the Packers can take their time with a decision on Jolly.
Permalink | Email This Blog
- You can log in to this system either through Facebook or using your JSOnline public profile. JSOnline public profile. Please note that your public profile login will be different than your JS Everywhere login.
- You can personalize your public profile with a photo. You can also use that profile to sign up for email newsletters and alerts.
- While we strive for a lively and vigorous debate of the issues, we do not tolerate name calling, foul language or other inappropriate behavior. Please see our discussion guidelines and terms of use for more information.
- While we do our best to moderate comments, we do not screen comments before they are posted. If you see a comment that violates our guidelines, please use the "Report Abuse" link to notify us of the issue.
- We reserve the right to close commenting on specific stories.
Nice. I'd like to see this guarantee him a chance to fight for his roster spot.
Hopefully he has done his part to remain at something close to playing shape and won't embarass himself or the team in August.Hide replies
For right now they can hang onto his rights. I wonder if after the draft and undrafted FA signings will push them to cut him to use his roster spot on a prospect.
This WAS a nice move, wasn't it? That's pocket change, and TT might be getting the answer to our need for another good pass rusher for it. It potentially could be a decent deal for JJ if he manages to pick up where he was before the suspension.
I don't remember him being much of a pass rusher. He only has 2 sacks in 4 years but he was good at knocking passes down at the line.
Knocking passes down and blocking kicks was all he could do. The only thing Jolly is fighting for is an NFL paycheck.
From what I recall, $715K is more than the minimum for a veteran. It sounds like the team is sending at least a tiny little vote of confidence in JJ's direction.
Jolly has a huge addiction issue, which everyone knows. But if he can stomp that down--and previous legendary Packers have managed to stomp that same thing down--he could be not just good, but perhaps kind of an inspiration, to this defense and this team.
Anyway, I would love to see him slapping down some passes like a JJ Watt, on the line of scrimmage.Hide replies
$715,000 is the 2013 league minimum for a player with 4 years experience, so it's not a vote of confidence (not that one was warranted for a 3 time felon), just a move to buy time and see what kind of shape he's in. Three years removed from an NFL workout program leads me to believe his strength and endurance will be at a level just above couch potato and just below bar league flag football player. Wouldn't be surprised to see him get cut shortly after the draft (hopefully sooner).
If Johnny Jolly is an inspiration to anyone I need to quit watching pro sports. I assume the "previous legendary Packer" you are speaking of is Brett Favre. Even he would be embarrassed to be mentioned in the same sentence as Purple Drank Jolly. Comparing him to JJ Watt is just laughable.
Low risk, high reward...at least for the Packers. Hope it works OK for Jolly.
No way this bum makes the team. He basically threw his career away. Gave up three of his prime years for "purple drank".
Out of the slammer and into more than double the salary of the average surgeon. What a system we allow to exist.Hide replies
More people are qualified to be surgeons than NFL caliber D-lineman.
JTBA is right!
D-Lineman qualifications: 1) IQ above -4; 2) strong; 3) if not strong, immovably fat.
Yeah, tough to do that.
Blame his union and the collective bargaining agreement for that, not the system. That is low pay for what he does. There is one irrefutable fact in dealing with recovered addicts, if they do not resume a career or find a decent job the chance of them falling back into the abyss increase exponentially. I think everyone should get a second chance to get back on their feet and establish themselves in society as a contributing member. And maybe, just maybe, he might help this team. No ikn e deserves to be thrown back into the gutter.
"Blame his union and the collective bargaining agreement for that, not the system."
That is a BIG part of the "system" with the owners having agreed to it.
If it turns out he's kept in shape and manages to make the team, I for one will give him a standing O when he walks out onto the field in September. It's easy to criticize former drug addicts, everybody deserves a second chance.
He isn't a former drug addict. 'Former' and 'addict' don't go together. Hope he beats his demons.
I agree hounze, he and others like him deserve a standing ovation just for beating he addiction demon. And if he succeeds with a career come back it gives him a platform and a beacon of hope for others fighting addiction in and out of sports. Life in general is much more important than sports. What I have seen in this blog is a lot of pompous people kicking a man when he is down. Never judge another man until you have walked a mile in his shoes.
$85K above minimum for vet.Hide replies
Nope, $630,000 is league minimum for a player with 3 years experience. $715,000 is league minimum for a player with 4-6 years (which is where Jolly falls).
TT wouldn't give Dietrich-Smith an extra $700,000 to virtually guarantee his return and he started games last year. Do you really think he'd give a guy that has shamed the team on multiple occasions a nickel more than he had to?
Depends on the talent level.
Although character is an important part i the time an illness like addiction is different than fighting dogs which is more of a behavioral issue. Was anyone spewing the same venom at Brett Favre when he fought his addiction problems? Brett was given a second chance and suceeded, John deserves the same chance.
It'll be interesting to see what kind of shape JJ is in...did he know he was going to be reinstated and kept in shape? I suppose we'll know very quickly where he stands...Hide replies
I think that is the most interesting thing out of this whole deal.
Is he in shape?
It would be really interesting to see what kind of shape he is in. Obviously he is not in playing shape, but if he was been able to at least somewhat keep up with workouts it should be interesting. Training camp is months away, he has plenty of time to get into shape for that if the Packers decide to keep him that long.
This guy is a menace when on the field and playing. Maybe kicking the tires with Canty was just kicking the tires, and Ted wanted to keep Jolly the entire time?Hide replies
"This guy is a menace when on the field and playing"
He was also a menace off the field, apparently. Seriously, good move to keep his rights until they can determine where his mind and body are. He is still quite young and was a very effective DE in Caper's scheme. He might be highly motivated to turn his life around, and if not they cut him with minimal cap consequence. I hope it works out for both sides.
So what it your point? You basically reiterated everything I said. The guy made a mistake. Brett Favre was addicted to pain killers. Codene isn't that much different. He didn't kill anybody or get someone hurt. He was doing this to himself. The fact that the Packers are even considering keeping him says a lot about his talent level.
I think if Jolly is back to form he and Canty both have a place on the team. Those big guys wear down, look what happened to Raji two seasons ago. Large D lineman are hard to find and to find one with strength, endurance, and quickness are even harder to find. Habving several in rotation keeps them fresh for the crucial fourth quarter and is insurance against injury.
Saw this coming no way we pay him a million. We will see what he can do this season hope he can return to form otheotherwise hes done. Should hopefully help in some way.Hide replies
I agree. Low risk move - if Jolly can help the team, great. If not, no big deal. TT and MM are planning to get some help on the D-Line with or without Jolly.
Excellent move. Zero risk, possible reward.
Unlike so many people who do bad things and get off easy, Jolly has paid his debt to society.
I hope it works out. If not, nothing lost. This was an obvious move.Hide replies
I agree. I found the sentence to be quite harsh for simple possession. The fact they had to dismiss the charges initially until they could develop a test for the substance in the glass made me wonder, who did he piss off? Usually those charges lacking proof, unless it involved a sexual assault, homicide, or aggravated battery are dismissed and forgotten or plea bargained down.


text:
Sip a cup of coffee and talk one-on-one with Pelham School Board members about our schools.
This morning at 9:30 a.m. you can stop by the Bakery at Four Corners, 4668 Boston Post Rd., to talk and ask questions of some of the board members.
Patch editor Renea Henry will stop by, so if you can't make it, post your questions and comments for her to pass along.
Pelham school board members have three coffees planned through March and are ready to hear what is on your mind.
Public engagement chair Madeline Smith said, in lieu of the large community forums of previous years, the Board looks forward to meeting in small groups with parents and residents regarding the school budget and other issues.
Next month, there will be another opportunity to talk with board members on Wednesday, February 13, 7:30 p.m. at Rockwell's. M.A.D. Café on Friday, March 15 at 9:30 a.m. will complete the trio of events.


text:
At Outcome Resources, "Helping Hospices Succeed" is more than just a tagline, it is our mission and our primary focus every day. As we consult with our hospice partners, patient care is our number one priority. With patient care impacted by Medicare Part D guidance issued by CMS, Outcome Resources has provided our hospice partners with education via live webinars and consultations and supporting documentation via our Medication Reviews, and then we worked with NHPCO and the Hospice Action Network to change the rules.
As the sole hospice pharmacy partner to sponsor the Hospice Action Network Advocacy Intensive last month in Washington D.C., we are proud that our commitment to hospice advocacy has helped to result in revised guidance being issued by CMS. In addition to our team traveling to D.C. to meet with Congress, we also provided scholarships to 22 attendees of this year's Advocacy Intensive from around the nation, to ensure that as many legislators as possible were reached with this very important message regarding hospice and Medicare Part D. Thanks to all of us in the hospice community, including those of you who participated by calling in to speak with your congressmen and senators, our voices have been heard!
Revised guidance has been issued as of July 18th. This revised guidance does provide substantial relief of the burden for hospice providers since prior authorizations will only be required on the four categories identified as typically used in hospice: analgesics, antinauseants (antiemetics), laxatives, and antianxiety drugs (anxiolytics). Other drugs will not have to go through the PA process. You may read the full CMS Memo for more information.
We urge you to make special note that the guidance emphasizes the need for hospices to include a comprehensive written drug profile as part of the hospice plan of care. While this Medication Review meets the need for Conditions of Participation, it now also may be provided to a Part D sponsor during the PA process. Outcome Resources has provided the most comprehensive, best in industry Medication Reviews well before these requirements were put in place. We invite you to compare our Medication Reviews to what you are currently receiving. While these are the #4 reason for being cited in survey, no Outcome Resources partner has ever been cited for Medication Reviews.
To learn more about hospice advocacy and the hospice regulatory environment, join us at the Annual Pathways to Success Hospice Conference this November in Berkeley, California. Jon Keyserling of NHPCO will address Hospice Advocacy and Policy in 2015, and Susan Balfour will discuss Hospice and the Letter People, and how to keep up with regulatory changes. Drs. Glen Komatsu and Stephen Leedy will keynote the two day Conference, and you may earn up to ten contact hours of continuing education. View the Full Agenda and Register Today!
Photo: Outcome Resources CEO Dr. Martin McDonough Addresses Attendees at the Hospice Action Network Advocacy Intensive, June 2014
Esther Liu, PharmD, MSIA, CGP
HIS is a patient-level data collection tool developed as part of the Hospice Quality Reporting Program (HQRP), which can be used to collect data to calculate 6 National Quality Forum-endorsed (NQF) Measures and 1 modified NQF Measure. See below for a list of measures required:
1. NQF #1617 Patients Treated with an Opioid who are Given a Bowel Regimen
2. NQF #1634 Pain Screening
3. NQF #1637 Pain Assessment
4. NQF #1638 Dyspnea Treatment
5. NQF #1639 Dyspnea Screening
6. NQF #1641 Treatment Preferences
7. Modified NQF #1647 Beliefs/Values Addressed (if desired by the patient)
HIS is implemented as part of the FY 2014 Hospice Wage Index Final Rule issued last year in July 2013. To refresh your mind regarding HIS submission, you may visit the CMS website to view the training materials. CMS requires ALL Medicare-certified hospices to submit HIS data on ALL patients. Please be aware of the completion and submission deadlines. Data collection of HIS for each admission must be completed within 14 days and submitted to CMS within 30 days after admission. Data collection for HIS for discharged patients must be completed within 7 days and submitted to CMS within 30 days after discharge. If the hospice failed to be compliant in reporting patient admission/discharge data, this would impact its payment rate in fiscal year of 2016.
As a Pharmacy Benefit Manager, we help our hospice partners to collect data to fulfil HIS requirements related to medications. To learn about the different reporting tools we offer to our partners, please contact the clinical department at clinical AT outcomeresources DOT com or Submit Your Information and we will contact you directly.
Jennifer Chen, PharmD
On March 28th, FDA approved the over-the-counter Nexium 24HR (esomeprazole magnesium) 20mg delayed-release capsules. Nexium is part of a class of drugs called proton pump inhibitors (PPIs), which is commonly used for gastroesophageal reflux disease (GERD), erosive esophagitis and prevention of NSAID-induced gastric ulcers. This purple pill, previously available by prescription only, is now available over-the-counter providing patients who suffer from frequent heartburn an easier access.
However, Nexium 40mg delayed-release capsules still remains available by prescription only as well as other formulations of Nexium including Nexium I.V. and Nexium oral suspension. For patients with difficulty swallowing, the Nexium 24HR capsule can be opened and mixed in applesauce.
The status change to OTC does not take away its potential harms. Its side effects include headache, diarrhea, increased infection and bone fractures. In general, short-term use of PPI is safe. The approved OTC labeling is a 14-day treatment and may be repeated every 4 months.
As mentioned in a previous article, Nexium was the number 2 drug in "Top 100 Drugs by Sales" over the past year. The cost for Nexium 24HR is significantly lower than the prescription version (about 1/10th the cost of prescription Nexium). The OTC availability of Nexium 24HR provides another cost-effective alternative for hospice patients. Other PPIs available in OTC formulations are Prevacid (lansoprazole) and Prilosec (omeprazole).
Jim Joyner, PharmD, CGP
One of the most common sources of medication errors is the problem of "look-alike" and/or "sound alike" drug names. The risk for serious errors can arise when medication orders or prescriptions are not written clearly and the reader misinterprets the intended drug for a different drug with a very similar spelling. Another variation on this error theme is when a drug name is transmitted verbally (either directly or more likely, over the phone) which sounds very similar to a different drug. The listener may hear a different drug name than that which was intended. There are very many drugs that fit into these categories of look-alike and sound alike drugs, providing the clinician with a great many opportunities for misinterpretation. This table provides just a few examples. (You may wish to share this with your staff.)
There are a number of ways to reduce the risk for this type of error through increased clinician awareness of the problem, coupled with a variety of safe practices. Here are a few safe practices that are worth consideration:
• Put the drug name that you heard or read into the context of the overall medication order; does the strength, frequency for use, and reason for use make sense for the drug name?
• Know what the medication is intended to be used for. Is the drug name that you heard indicated or commonly used for managing that type of condition or symptom?
• If the person transmitting the order verbally is not clear or has an accent that you are not familiar with, ask them to spell it out.
• When initiating an order in writing or verbally, consider using both the brand name AND generic name.
• When initiating an order, consider including the "reason for use" in the medication order. Such as "for depression" or "for arthritis".
• When selecting drug line items from a computer data-base, keep in mind that look-alike drug names may appear consecutively in the list, making the incorrect selection a high probability. Double – check all selections for accuracy against the intended drug name.
• Some computerized drug data bases can be configured to change the appearance of look-alike drug names to draw attention to their dissimilarities. This is done with the use of "tall man" (mixed case) lettering.
• Develop a working knowledge of actual look-alike and sound-alike drug names. The Institute for Safe Medication Practices (ISMP) has a very extensive list of drug name pairs that have been reported as error related events of this type. The ISMP list is updated every few months. Refer to http://ismp.org for more information on this topic and other medication error issues.
Outcome Resources considered it an honor to recently sponsor the 2014 Hospice Action Network Advocacy Intensive in Washington, D.C. Together with over 200 hospice professionals we had the opportunity to share our hospice stories with nearly all of the nation's Senators and State Representatives. In addition, this year, twenty advocates whose hospice programs would otherwise be unable to afford it were able to attend the Hospice Action Network's Advocacy Intensive thanks to Outcome Resources scholarships. It is vital to bring these stories to Congress and have our voices heard on Capitol Hill.
The support of our elected officials is crucial to protect and preserve the hospice Medicare Benefit and to support legislation that positively affects those patients and families facing end of life. We are grateful to the Hospice Action Network for providing all of us involved in hospice the forum and opportunity to speak with a unified message in support of our daily efforts. During the meetings on the Hill with Representatives, Senators, and Legislative Assistants, this year advocates focused on requesting support with the issue of Hospice and Medicare Part D. (Learn more in our previous blog post about the issue.) As you may be aware, CMS issued guidance to the Part D provider and hospice communities introducing a "prior authorization" process for how the two groups should determine who pays for which drugs once a patient elects hospice. Since there is no uniform process in place, hospices are dealing with multiple Part D prior authorization processes and paperwork that in many cases requires the addition of staff, and patients are trapped in the middle of this confusing process – sometimes even deciding to disenroll from hospice or being left without medications.
To learn more about these issues or how you can help, please visit Hospice Action Network. You can also participate by calling your members of Congress. Outcome Resources has been involved as hospice advocates for many years and will continue to support these efforts at every opportunity. We are honored to have Jonathan Keyserling, Senior Vice President, Office of Health Policy and Counsel at the National Hospice and Palliative Care Organization presenting a session on Hospice Advocacy at the Outcome Resources Pathways to Success Conference by the Bay this November. To learn more about the Conference, visit the Conference Website or Download the Information Sheet.
View our photos of the HAN Advocacy Intensive on Facebook at http://on.fb.me/1m4GXvz.
Dr. Jim Joyner, PharmD, CGP
A recent article appeared in the Medscape News on-line site which presented the "Top 100 Drugs by Sales" over the past year. All of these drugs were brand-name products. The drugs made the list through a combination of two factors; popularity among prescribers and having a high cost. Thirteen of the drugs on this list are drugs that we see routinely prescribed for hospice patients to varying degrees. In light of limited hospice reimbursement rates and extremely tight budgets, it is appropriate for hospice organizations to evaluate current usage of these highly prescribed, high cost drugs. The remainder of this article will identify these drugs and discuss possible cost-effective alternatives.
First, the 13 drugs are presented here with corresponding reported $ sales figures for the past year (April 2013 – March 2014). Drugs are ranked from highest sales dollars to lowest:
Drug Sales in billions
Abilify 6.9
Nexium 6.3
Advair 5.1
Spiriva 3.1
Lyrica 2.6
Oxycontin 2.5
Celebrex 2.3
Namenda 1.9
Symbicort 1.7
Seroquel XR 1.3
Dexilant 1.0
Lunesta 0.9
Combivent 0.8
Abilify was the number one drug on the Top 100 list for highest sales overall. This is the most expensive antipsychotic drug available. Terminal delirium and related psychoses or agitation experienced by hospice patients may often respond very well to much less expensive antipsychotic drugs such as Haloperidol or Risperidone (about 1/30th and 1/5th the cost of Abilify, respectively).
There were 2 PPI's (proton-pump inhibitors) on the list; Nexium took the number 2 spot and Dexilant was number 56 on the Top 100. Effective management of gastric distress in hospice patients may often be achieved with the oldest generic PPI, Omeprazole. Omeprazole OTC is about 1/15th the cost of these two brand name PPI's.
Advair and Symbicort are both long-acting beta agonist (LABA) / steroid combination inhaler drugs which are dosed twice daily. Both are expensive. There are no low cost LABA/Steroid combination products currently available. One option for low-cost alternative therapy in hospice is to use the short-acting beta-agonist, Albuterol (four times daily), plus an oral steroid such as Prednisone 5 - 10mg daily. Long term use of oral steroids is associated with higher incidence of side effects, however, in the hospice setting such long-term use may not be a relevant concern. The Albuterol plus Prednisone option would be about 1/10th the cost of the Advair or Symbicort.
Two other inhaled respiratory medications on the list were Spiriva and Combivent metered dose inhalers (MDI'S). Spiriva is an anticholinergic-type bronchodilator (tiotropium) and Combivent is the combination of the anticholinergic bronchodilator, Ipratropium, and the beta-agonist bronchodilator, Albuterol. While there is no low cost alternative to these products in metered-dose-inhaler (MDI) dosage form, there is a good low cost alternative in the nebulizer solution dosage-form of the albuterol-ipratropium combination product, also known as Duoneb (about ½ the cost of Spiriva or Combivent therapy).
Lyrica is used for both seizure management and control of neuropathic pain in hospice patients. A reasonable cost-effective alternative is Gabapentin which is about 1/4th the cost of Lyrica in equivalent doses.
Oxycontin is one of the most expensive long-acting opioids available. Methadone is a very effective alternative at about 1/30th the cost for an equivalent dose. Methadone also has the advantage of being available in a liquid dosage-form for those patients who have difficulty swallowing whole tablets. Oxycontin tablets should not be crushed. Morphine Extended Release tablets may also be a reasonable alternative at about 1/3 the cost of Oxycontin. Like Oxycontin, the morphine extended release tablets should not be crushed.
Celebrex is a Cox-2 selective non-steroidal anti-inflammatory (NSAID). This is the only cox- 2 selective NSAID currently available and therefore has a distinct advantage in patients where there is significant concern or history of NSAID induced gastric side effects. Alternatives for patients that are not in that category would in include Naproxen, Ibuprofen, and Meloxicam. These options are all about 1/10th the cost of Celebrex in equivalent doses.
Namenda may be effective for management of cognitive symptoms encountered in moderate to severe dementia. There is no evidence that this drug has any significant benefits in "end-stage" dementia, classified as Level 7a or greater using the FAST rating scale. By definition, a patient with a hospice diagnosis of dementia would be at Level 7a or greater, so continued therapy with Namenda would not be recommended once the patient is admitted to hospice with this diagnosis.
Seroquel XR is the extended-release (once daily) version of the antipsychotic drug, quetiapine immediate release (twice daily). Quetiapine immediate release is available as a generic and is less expensive than the XR form with only minimal adjustment for dosage compliance (one dose per day vs two). An even more cost-effective option is Haloperidol which is about 1/12th the cost of generic quetiapine in equivalent doses.
Lunesta is a sedative-hypnotic which is used for management of insomnia in hospice patients. Lunesta has recently gone generic (Eszopiclone), however, even that version is still pricey. There are a couple of cost-effective alternatives: Temazepam (a benzodiazepine sedative hypnotic) and Trazodone (a sedating antidepressant). Trazodone and Temazepam have been used extensively in hospice for managing insomnia with good results. Both of these alternatives are about 1/15th the cost of Eszopiclone.
Conclusion: The cost-effective alternatives discussed in this article may not be appropriate for all hospice patients, and consideration of the individual patient's drug history and comorbid conditions need to be factored into any decision to change medications. On the other hand, each of the alternative medications suggested here have been widely used in hospice and palliative care settings for long periods of time with positive results. While not appropriate for all patients, these alternative medications should be considered as possible first-line therapies for the majority of hospice patients.
For additional information on equivalent doses and corresponding costs, there are some helpful Hospice Medication Charts on the Outcome Resources website that provide detail about inhaled respiratory medications, PPI's, and benzodiazepines. You can find these under Clinical Resources in the member's section. Outcome Resources hospice clients can also contact our clinical pharmacist staff for specific recommendations as needed.
Dr. Jim Joyner, PharmD, CGP
I am pleased to announce that the online education section of OutcomeResources.com has been updated with a new course: "Wound Care for Hospice Patients." This is a very interesting and informative course that addresses the complex issues of wound management in hospice patients. Our presenter is wound care specialist Kristen Lyn Brodrick, RN, BSN, CHPN, CWCN. The unique challenges of wound care management in hospice patients is presented through the eyes of a wound care specialist and certified hospice & palliative nurse. A description of the wound healing process sets the stage for this informative presentation, followed by a detailed discussion of the types of wounds encountered in the hospice patient. Information about the staging of various wounds is explored. The presentation concludes with specific guidance about the role and application of various treatment modalities including a variety of wound care dressings and debridement. This program is approved by the California Board of Registered Nurses (BRN) for 1 contact hour of continuing education*. Outcome Resources partners may log on to the Members Only section of OutcomeResources.com to register for this course.
There are also two companion articles which appeared in the Outcome Resources newsletter, The Clinician, which may be of interest to those exploring this topic:
"Wound Care and the Hospice Patient: The Perspective from a Wound Care Specialist"
Kisten Lynn Brodrick, RN, BSN, CHPN, CWCN
January 2014 Volume 9, Issue: 1
"A Discussion About Wound Care Products and Factors That Impeded Healing"
Jim Joyner, PharmD, CGP
October 2013 Volume 8, Issue: 4
Registration is now open for our Annual Conference, Pathways to Success: Conference by the Bay, which will be held November 12th-13th in Berkeley, California. An expert panel of speakers will be addressing hot topics in both clinical and administrative tracks, and you will have the opportunity to earn up to 10 contact hours of continuing education.* Learn more about this exciting hospice and palliative care conference at www.outcomeresources.com/hospice-conference.
(*Provider approved by the California Board of Registered Nursing, Provider Number 14850)
Dr. Julia Harder, PharmD, CGP
Agitation is a common symptom experienced by hospice patients with Alzheimer's Disease (AD), and is associated with significant distress on the part of patients, caregivers, and healthcare professionals. Current treatment options include non-pharmacologic management strategies, which are first-line but frequently insufficient, and pharmacologic strategies. The antipsychotics (such as haloperidol, risperidone and quetiapine) are the cornerstone of pharmacologic management of agitation in AD, but these medications are associated with increased mortality in elderly patients with dementia. In recent years, the use of antipsychotics for this indication has been widely discouraged by the FDA, and their use has been under scrutiny and investigation. New and better therapies for agitation associated with AD are direly needed, especially in hospice.
The Citalopram for Agitation in Alzheimer Disease (CitAD) Study was recently published in the Journal of the American Medical Association. This randomized, placebo-controlled, double-blind, parallel group trial of 186 patients with Alzheimer's Disease and persistent moderate to severe agitation found that citalopram (at a dose of 30 mg per day) significantly reduced agitation and caregiver distress. However, this benefit was tempered by an increased risk of cardiovascular adverse effects, specifically prolongation of the cardiac QT interval.
Study participants were randomized to receive psychosocial intervention (educational materials, counseling, 24-hour crisis management) plus either citalopram or placebo for 9 weeks. Citalopram dosage began at 10 mg per day, with titration to 30 mg per day over 3 weeks based on response and tolerability. The majority of patients ended up taking the full 30 mg target dose. After the start of the study, the FDA issued its advisory that citalopram should not be prescribed at doses over 20 mg in patients older than 60 years because it causes dose-dependent QT prolongation (see our previous blog post on this topic). This advisory led the study investigators to include strict electrocardiogram (ECG) monitoring, and to exclude from the study any patients who showed QT prolongation on ECG.
At week 9 of the study, the analysis found a significant improvement in the treatment group compared with the placebo group on the 18-point Neurobehavioral Rating Scale-Agitation (NBRS-A), which assesses agitation, hostility/uncooperativeness, and disinhibition, with higher scores indicating more severe symptoms. The mean estimated treatment effect on the NBRS-A (the difference in scores at week 9, controlling for baseline score and MMSE score) was –0.93 (95% confidence interval, –1.80 to –0.06; P = .04).
In addition, 40% of the patients receiving citalopram had moderate or marked improvement from baseline severity on the 7-point modified Alzheimer's Disease Cooperative Study–Clinical Global Impression of Change score, which assesses items specific to agitation in AD. This compared to 26% of the patients taking placebo.
According to the study's lead investigator, Dr. Anton Porsteinsson, this effect of citalopram on agitation is about the same as that of atypical antipsychotic drugs, such as quetiapine and risperidone.
The downside is that patients in the treatment group did show QT prolongation (18.1 ms; 95% CI, 6.1-30.1; P = .01) compared to the placebo group. "Our findings support the FDA," said Dr. Porsteinsson. "If nonpharmacological intervention is not beneficial, judicious use of citalopram appears to have a role in managing agitation in patients with Alzheimer's disease, but generally, the dose should not surpass 20 mg per day."
The study didn't include enough patients taking 20 mg of citalopram to determine whether this dose affected the QT interval or whether it also led to reduced agitation. So, next on the research agenda is applying for funding to look at 20 mg as the target dose, said Dr. Porsteinsson. "The aim is to treat people with clinically meaningful agitation and see if that dose has similar agitation efficacy and if it reduces caregiver burden to the same degree, but without the QTc findings."
Porsteinsson AP, Drye LT, Pollock BG, et al. Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial. JAMA 2014;311:682-691.
Dr. Julia Harder, PharmD, CGP
Drug overdose deaths, driven largely by prescription drug overdose deaths, are now the leading cause of injury death in the United States – surpassing motor vehicle crashes. Opioid overdose, in particular, has been steadily rising over the past decade, and has been the subject of intense FDA focus and regulation.
As we know, naloxone is an opioid receptor antagonist that rapidly reverses the effects of opioid overdose and is the standard of care. However, existing naloxone drugs require intravenous administration and are most commonly used by trained medical personnel in emergency departments and ambulances.
Yesterday, the FDA approved Evzio (naloxone HCl injection, manufactured by Kaleo, Inc.) for the emergency treatment of known or suspected opioid overdose. Evzio is a hand-held auto-injector that rapidly delivers a single 0.4 mg dose of naloxone as an intramuscular or subcutaneous injection into the thigh. The auto-injector, which is about the size of a cell phone, can be carried in a pocket or stored in a medicine cabinet, to be used by family members or caregivers in the case of suspected opioid overdose, as manifested by respiratory and/or central nervous system depression (e.g., extreme sedation or loss of consciousness). Evzio is approved for use in adult and pediatric patient (even infants).
Evzio is not intended to be a substitute for immediate medical care. The duration of action of most opioids exceeds that of naloxone, meaning that respiratory and/or CNS depression may recur after an initial improvement in symptoms. Therefore, the administrator should always seek immediate medical attention after giving the first dose of Evzio, and should repeat doses of Evzio every 2-3 minutes, depending on the patient's response, while waiting for emergency medical assistance.
Evzio was reviewed under the FDA's priority review program and was also granted a fast track designation. Evzio is expected to be available this summer as a carton containing 2 prefilled auto-injectors and a single Trainer injector.
|in patient that's been on a winitag list for proper pain management for as long as I can remember.I am familiar with the problem.I live in British Columbia,Canada.Where a witch hunt in the 80 s took the licenses of most,if not all,doctors that dared to take pain on.It is now impossible to find a family doctor that will prescribe even minimal amounts of opiates.I have a specialist and have had to go to a methadone clinic to get an amount of morphine that works for a small portion of the day.I have to take methadone as well,as those are the rules.The methadone is an agonist and decreases the effect of the morphine.In a mis-guided attempt to prevent a few people from abusing drugs.A whole province has to do without proper pain management.What you describe is only the beginning.That picking off of single doctors will only satisfy the DEA for a time.They will probably go after all doctors prescribing opiates eventually.Like the government did here.
-- Afchen
Posted 6/5/2014 10:10:26 PM
|Our society lives in daenil or ignorance. The lack of truth and transparency about drug abuse is similar to how mental illness was looked at in earlier years. We need to shout out with the strongest voices and most caring hearts in favor of strict guidelines for prescription drugs, and do whatever we can to prevent pharmaceutical companies from promoting usage for their monetary gain. Please support Oxy Watchdog in whatever way you can.
-- Vinh
Posted 6/5/2014 12:46:50 PM
Dr. Julia Harder, PharmD, CGP
On September 30, 2013, a new antidepressant, vortioxetine (Brintellix™ -- Lundbeck and Takeda), was approved by the FDA. Vortioxetine is considered a "multimodal antidepressant", which puts it in a class of its own. This blog post will summarize important points about the clinical use of vortioxetine, especially in the hospice population, in whom depression is very common.
Mechanism of Action
Vortioxetine is thought to work through a combination of both serotonin reuptake inhibition and serotonin receptor activity, including agonism at the 5-HT1A receptor and antagonism at the 5-HT3 receptor. As a result of this multimodal and partially novel mechanism of action, vortioxetine may hold promise for patients who have failed to respond to first-line treatment options. Vortioxetine may also have beneficial effects on cognition, which is currently being investigated further.
Efficacy Data
Data from both short- and long-term randomized controlled trials (RCTs) have demonstrated vortioxetine's efficacy both in the treatment of major depression and in preventing relapse. International data have shown significant efficacy of vortioxetine in a dose range from 5 to 20 mg/day but most consistently at doses of 10-20 mg/day. Two low-dose studies, (2.5 mg/day and 5 mg/day of vortioxetine) did not show superiority over placebo. Furthermore, antidepressant efficacy has been demonstrated specifically in an elderly population (mean age, 70.6 years), which is unique among the antidepressants. An RCT of more than 450 elderly adults with major depressive disorder from 7 countries showed that those treated with vortioxetine showed significantly greater improvement on several depression rating scales and cognitive tests compared with those who received placebo.
Vortioxetine has also shown efficacy in patients who have already failed a first-line antidepressant. The REVIVE study compared the efficacy of vortioxetine with the most recently approved novel antidepressant in Europe, agomelatine, in a well-powered, head-to-head trial. Of note, the patients were non- or partial responders with a history of at least 6 weeks of treatment with an SSRI or SNRI who were then abruptly switched to 12 weeks of randomized treatment with either vortioxetine (10-20 mg/day) or agomelatine. In this "out of class" switch strategy for patients with insufficient response to first-line antidepressants, vortioxetine led to significantly greater improvement in depression scores at 8 weeks compared with agomelatine, with similar effects at week 12.
Finally, on the basis of its mechanism of action, vortioxetine is being studied for potentially beneficial effects on cognition. Initial data on the potentially procognitive effects of vortioxetine, independent of the drug's effects on symptoms of depression, have been generated in elderly patients with major depressive disorder. Other studies with cognition as a primary outcome are ongoing.
Safety Data
The most common adverse effects of vortioxetine across multiple studies were nausea, diarrhea, dry mouth, sweating, and headache – standard antidepressant side effects. Of these, nausea seems to be the most common. The potential benefits of vortioxetine include low rates of sedation/somnolence and insomnia, low weight gain in both short- and long-term studies, and less sexual side effects than the SSRIs.
Like other antidepressant medications, vortioxetine has an FDA boxed warning and a medication guide alerting patients and healthcare professionals that antidepressants can increase the risk for suicidal thought and behavior in children, adolescents, and young adults aged 18 to 24 years during initial treatment.
The recommended starting dose is 10 mg orally once daily, taken at any time and without regard to food intake. The dose should then be increased to 20 mg/day, as tolerated, with consideration being given to lowering the dose to 5 mg/day for patients who do not tolerate higher doses. Vortioxetine is currently available as brand-name only (Brintellix™), in 5 mg, 10 mg, and 20 mg tablets.
Vortioxetine has a favorable pharmacokinetic profile. It is metabolized by several different liver enzymes (rather than predominantly just one or two), which means that is does not have many drug interactions beyond the normal ones we are familiar with (tramadol, linezolid, methylene blue, monoamine oxidase inhibitors, triptans) that interact with all serotonergic antidepressants. Vortioxetine also has a long half-life of about 60 hours, which means that rebound or withdrawal will be unlikely if patients miss doses or have to abruptly discontinue the medication due to the loss of swallowing ability.
Currently, Brintellix™ is one of, if not the, most expensive antidepressants on the market, with an average wholesale price of $8.72 per tablet (same price for all strengths). By comparison, levomilnacipran (Fetzima™, another new antidepressant approved in 2013 that is still brand only) is $8.10 per tablet, escitalopram is about $4.50 per tablet, and citalopram is about $2.50 per tablet.
Place in Hospice Therapy
Vortioxetine has many positive characteristics, including a multimodal mechanism of action, demonstrated efficacy in the elderly, favorable pharmacokinetics, and a relatively short list of side effects. However, because of lack of clinical experience and very high cost, vortioxetine should not be used as a first-line agent for the treatment of depression in hospice. As a result of the diverse and partially novel mechanism of action of vortioxetine, this new multimodal antidepressant may hold promise for a very select group of hospice patients, including:
• Patients who have tried and failed other first-line therapies, including one or more SSRIs
• Patients who have experienced intolerable sedation/somnolence or insomnia with other antidepressants
• Patients with comorbid cognitive deficits
The broader picture of vortioxetine's clinical utility and place in the treatment of patients with depression will need to be established through its clinical use after approval and ongoing and future phase 4 trials. Future studies will hopefully examine whether vortioxetine has more robust efficacy in certain patient subgroups, including treatment-nonresponsive/resistant patients and those with comorbid cognitive problems, as this would be of particular interest to the hospice community.
|First 10
|<<Previous 10
|Next 10 >>
|Last 10
Education Resources and Support for Hospices
Stay up-to-date on the latest hospice pharmacy benefits management information and tools with a variety of education resources and support at no extra charge. We offer presentations live at your facility, over the Internet or viateleconference, online service education programs, customized courses, and courses accredited for nursing continuing education credit.
Clinical Services
Our palliative care experts provide clinical consulting on important medication management and care decisions. Our non-dispensing pharmacists provide focused attention and unbiased advice.
Read more about our clinical pharmacy benefits management services>>
Why Use A PBM?
Contracting with multiple pharmacies, doing all the reporting, trying to stay current with medical practices and stay compliant while keeping costs down? There's an easier and more effective way.
Find out how using a pharmacy benefits manager (PBM) can help you>>


text: MCDB 131 Medium without L-Glutamine (ATCC® 30-2603™) General Information Quality Control Specifications Documentation Print Email Share Share this product Facebook Twitter Google+ Permits and Restrictions View Permits Product Format 500 mL Storage Conditions Store medium at 2°C to 8°C in the dark when not in use. Applications MCDB 131 Medium provides a defined and nutritionally balanced environment for mammalian cell culture. The medium includes trace elements and higher levels of certain vitamins and amino acids compared to basal medium. MCDB 131 Medium was originally developed for human microvascular endothelial cell (HUVEC) culture, but supports the growth of other cell types, including hepatocytes, smooth muscle cells, and cardiac myocytes. Comments Supplement with glutamine prior to use. For vascular endothelial cells, 10 mM glutamine (final concentration) is recommended. For other cell lines, 2 mM glutamine (final concentration) is generally required; however, the optimal concentration is dependent on your cell line of interest. Biosafety Level N/A Quality Control Specifications Sterility tests are performed on each lot of medium using current USP methods. Each lot of medium is also tested for the ability to support the growth of several different cell lines using both sequential subcultures and plating efficiencies. pH, osmolality, and endotoxin tests are also performed as indicated below. Test* Specification pH 7.2 to 7.6 Osmolality 260 to 300 mOsm/kg H2O Sterility Testing Pass Endotoxin ≤ 0.25 EU/mL Mycoplasma Negative Growth Promotion Pass *Please consult the Certificate of Analysis for lot-specific test results. Permits These permits may be required for shipping this product: Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment. Basic Documentation Product Sheet Certificate of Analysis MSDS Other Documentation Formulation


text:
|epithelium (ˌɛpɪˈθiːlɪəm)
|—n , pl -liums, -lia
|an animal tissue consisting of one or more layers of closely packed cells covering the external and internal surfaces of the body. The cells vary in structure according to their function, which may be protective, secretory, or absorptive
|[C18: New Latin, from
epithelium ep·i·the·li·um (ěp'ə-thē'lē-əm)
n. pl. ep·i·the·li·ums or ep·i·the·li·a (-lē-ə)
Membranous tissue composed of one or more layers of cells separated by very little intercellular substance and forming the covering of most internal and external surfaces of the body and its organs.
|epithelium (ěp'ə-thē'lē-əm) Pronunciation Key
Plural epithelia
The thin, membranous tissue that lines most of the internal and external surfaces of an animal's body. Epithelium is composed of one or more layers of densely packed cells. In vertebrates, it lines the outer layer of the skin (epidermis), the surface of most body cavities, and the lumen of fluid-filled organs, such as the gut or intestine.
epithelial adjective


text:
The Gowanus Canal is much more than a polluted waterway – it is a natural habitat, an industrial passageway, and, as we found out, a great way to escape the city.
And the best way to see all of this? From a canoe.
Our guides were Owen Foote and Ray Howell of the Gowanus Dredgers Canoe Club, a member organization run by volunteers that leads canoe rides along the waterway. The Dredgers have a permanent trailer on the Canal, at 2nd Street just past Bond, which is filled with canoes and paddles.
On Wednesdays and Saturdays, head to the Gowanus and take a boat out, for free!


text:
Propelled by DiscomfortFriday, September 20th, 2013
"The truth is that our finest moments are most likely to occur when we are feeling deeply uncomfortable, unhappy, or unfulfilled. For it is only in such moments, propelled by our discomfort, that we are likely to step out of our ruts and start searching for different ways or truer answers." -M Scott Peck
We resist change. We prefer our known discomfort to the fear of what we don't know. We stay in jobs we don't like, we stay in relationships that are toxic, we stay in mindsets that keep us trapped in familiar ways of perceiving the world even and often in spite of the regular messages our body is giving us about how uncomfortable we are. Often, without our own witness, we fabricate stories that spin our discomfort into choices that we wouldn't actually be making if we had the courage and insight to squarely look at our fear of the unknown. I keep thinking about the classic tale of the frog that is placed in a pot of cool water and is slowly boiled to death. We all have some of that amphibian brain that chooses the slow boil over the leap into the unknown.


text:
Introduction to PLC
This training is focused on students with a basic understanding of programmable logic controllers and how they function in industry. The class will focus on the more advanced features and functions that the PLC is capable of providing in an automated manufacturing system. The Allen-Bradley software will be used.
Click here for a course outline


text:
Five months after Hurricane Sandy ravaged shore towns throughout New York and New Jersey, most people in the region have gone back to their regular routines. But for many people in the hardest hit communities along Long Island's south shore, life is anything but normal. (See You Tube footage and comments from Oceanside residents http://bit.ly/ZTQ6g4 ).
Oceanside Community Service has already raised and
distributed $100,000 to help beleaguered residents and says that more
assistance is needed.
In an effort to raise an additional $75,000 to help
residents in local communities, Oceanside Community Service and Oceanside High
School, in partnership with the NCAA Women's Lacrosse Teams from Columbia
University, Yale University, Molloy College and Southern New Hampshire University,
will host a major lacrosse-themed fundraising event at Oceanside High School on
April 13 to benefit Hurricane Sandy victims in the hard-hit south shore Long
Island towns of Oceanside, Island Park, Long Beach and surrounding areas. Island Harvest will also participate in the
The event will feature two Women's College Lacrosse
games: Division I Columbia V. Yale and
Division II Molloy V. Southern New Hampshire.
There will also be LAX scrimmage
and clinics for elementary school-aged girls, music by popular Long Island bands
Mystic and Permission to Launch, a U.S. Marine Corps Color Guard, bbq, activities
for children, and giveaways for people impacted by hurricane Sandy.
"Our mission at Oceanside Community Service has always been
to lend a hand to our neighbors in need. We won't stop until everyone is back
in their homes," said Robert M. Transom, head of Oceanside Community Service
and also a trustee on the Oceanside Schools Board Of Education.
According to Mr. Transom, many families are still struggling
financially because insurance and FEMA funds to help them remediate their homes
has not come through. There are still homeowners who have not even begun
reconstruction because they simply don't have the funds.
For more information, contact Donna Kraus @ 678-7525.


text:
Karmen Pedaru
Yet, it's not just Pedaru's hero jackets that have us spellbound by her personal style; we also admire how she composes her more laid-back off-duty looks. To complete these effortless ensembles, Pedaru often reaches for a classic black blazer to offer polish and depth. Backstage at Calvin Klein's S/S 09 show (bottom left), she used an Elizabeth and James blazer to upgrade a casual outfit, consisting of a boldly graphic Diesel tee and Dolce & Gabbana Sandals ($725) from their S/S 08 safari-inspired collection. That same season, backstage at Marni's S/S 09 show, she paired a fitted Stella McCartney blazer with gray Pepe jeans and an eye-catching flannel shirt. She finished off the look with MICHAEL Michael Kors' Luggage Amherst Shoulder Bag ($398)Â--a great neutral go-to accessory she also wore backstage at Preen's F/W 09 show to accent her Thakoon top, Cheap Monday jeans, and Gucci leather boots.
While recreating Pedaru's passport is no easy feat, we've sleuthed out all the pieces you need to let her style take flight for you. If you're in the market for some statement off-duty outerwear that will have you looking MOD in no time, try M.E.R.S.H's Fleece Lined Faux-Leather Short Jacket ($108), Youareagirl's Fleece Lined Faux-Leather Short Jacket ($200), or Express' (Minus The) Leather Moto Jacket ($98), if you'd like a more Balmain-inspired tough-girl style. However, if Pedaru's penchant for blazers piques your interest, we'd recommend Sparkle and Fade's Shawl Collar Blazer ($78), Silence & Noise's Cropped Blazer ($68), or Madewell's Sweatshirt Jacket ($78). Throw any of these ladylike staples over Madewell's Picnic Shirt ($69.50) or Ahniimura's Jessica Alba Tee ($81) and you'll have mastered an off-duty look worthy of Pedaru's personal style file.
However, while the aforementioned items should get you started on the road to Pedaru-inspired ensembles, we've discovered a few more must-haves to help you look model-worthy at every turn. Of absolute importance, bien sur, is a staple pair of black leather pants or leggings like Pedaru's Givenchy version. We'd invest in Manoush's Skinny Fit Luxury Perforated Leather Trousers ($4134) to give any year-round ensemble an instant upgrade, or Topshop's Panelled Wet Look Leggings ($44) for a leather-like look. Finally, don't forget your Pedaru-approved footwear, an imperative component for any completed ensemble. Opt for Matter Bernson's KM Gladiator Sandals ($169) in Gold Crackle or J. Crew's Cyprus Metallic Gladiator Sandals ($69.99). Looking to recreate Pedaru's backstage-chez-Calvin Klein outfit? Pick up JS by Jessica's Heidi Booties ($69.95) to finalize an outfit that's just as worthy of roaming the streets of Paris as Pedaru's stylish own!Â--Liza Kaplan
Next Up:
Celebrity Feature: Jennifer Lawrence


text:
GameFace GF76 AEG Carbine Airsoft Rifle - BlackItem Number: 13040469
Price: $129.99 $139.99*
You save: $10.00 (7%)
You save: $10.00 (7%)
Free Shipping Eligible on Qualifying Purchases Over $25! Up to $15 Shipping Credit. (See Promotion Details)
Product Information
Customer Reviews
The GameFace GF76 AEG Carbine Airsoft Rifle shoots 6mm plastic BBs and features full or semi-automatic options. The attached high capacity magazine is excellent for airsoft competition. It uses a rechargeable NiMH battery to power its wave of BBs. With muzzle velocities of up to 375 fps, you can be sure to spray areas quickly.
- Power source: rechargeable battery
- Caliber: 6mm plastic BBs
- Weight: 4.5lbs
- Front sight: elevation adjustable post
- Rear sight: elevation adjustable notch
- Safety: lever
- GameFace
DISCLAIMER: The sale or shipment of this product to residents of California, Connecticut, District of Columbia, Delaware, Illinois, Michigan, Massachusetts, New Jersey, New York, and Puerto Rico is prohibited. We recommend the use of protective eyewear whenever using or near the use of this item.
Country Of Origin: Mexico
Customer Reviews
Rated 4.2 out of 5�by 52 reviewers.
Rated 4 out of 5�by Trashmaster42 Good gun This is a good gun for any beginner just starting out. If you're an intermediate or advanced player don't even consider this weapon. It has an ok velocitie and can shoot pretty quickly. Mine chronoed at 297 fps last time I went somewhere and i got 15 kills with it for the whole day. The one thing I do suggest doing is using .20 gram BB's or higher, such as .25-.30, to get a more accurate shot. It will however slow the speed down in fps. June 23, 2014
Rated 2 out of 5�by mike Save your money I bought the gun, used it for about an hour stopped working. Returned it got a new one, tested it out to make sure it worked my war. I went to the war and it wouldn't work. Other than my issues the gun had a nice rate of fire, nice fps, but you'll need a lot of ammo. If you like taking it back or fixing it every hour, it's not for you. April 27, 2014
Rated 4 out of 5�by That Sneaker Head Great Gun This Gun is very good should be a great pickup for starters. BTW The battery takes a little while to charge Just BE AWARE April 14, 2014
Rated 5 out of 5�by bapk bast gun ever! two of my friends have this gun. it the best gun I've ever fired! great rate of fire! great range! great accuracy! best gun for your money! the only issue is that both my friends had to buy an additional battery because the one it comes with is very poor. our next fight is coming up and ill be buying it for the battle. its a great sniping gun. we often snipe people from with it. everyone runs the other way when it comes out. its devastating when combined with a co2 pistol. April 11, 2014
Rated 4 out of 5�by e dog pretty good Not super fast. shoots about 50 yards with hop up. Also i got the gun and before the warranty ended my gun broke. I shipped it back to New York, and they sent a brand new gun with 5 thousand horrible ammo as reimbursement for the shipping. Excellent for starters. 20 gram bbs are what you should shoot through it February 2, 2014
Rated 5 out of 5�by firehead57 Great gun Its a great gun with a great hop up system and it works great with my .12 BBs. it is pretty expensive but its worth its money any BB weight works with it great January 29, 2014
Rated 5 out of 5�by nein good gun, 1 problem i got this gun for christmas, used it two days after christmas in a airsoft war, it was great! shot perfectly, powerful, and accurate. so heres the facts: PROS: durable fast accurate powerful metal components very comfortable very ergonomic CONS: the stock is loose since it is a folding stock i guess that will happen selector switch shakes when being shot January 22, 2014
Rated 5 out of 5�by a soft23 Best Gun I bought this gun and it worked amazing. Nothing has broken on it so far and it shoots very accurate. It has a very good hop up system. I bought this gun in the summer and nothing has broken yet. It shoots best with .20g bb's and it stings if you get hit. January 7, 2014
Rated 5 out of 5�by Grantc Amazing This is good for anything it has easy mag release and great acuracy January 4, 2014
Rated 5 out of 5�by dPowell it is awessome this gun need heavy ammo i don't recommend buying .6 or .12 it is to light for the gun i would recomend buying some .20 ammo for the gun it will be 20 times more accurate and it wont spin as much as the .6 or .12 but over all this gun is awesome fro teens to go have a fight i dominate. It you are looking for a 1x sight go to dicks and ask about a tiny red dot sight it will be around 40 dollars but it is soooo useful P.S. good christmas present October 20, 2013


text:
Small Things
A Poetry Chapbook
By Meredith Mason
About the Author
Publish Date January 01, 2013
Dimensions Pocket 26 pgs
Color printing (on white uncoated paper)
Category Poetry
Sign in or create an account to post a comment.
Start your own book today from US $3.99.
Get Started
Blurb Sites


text:
Weekend Box Office Report: 'Lone Survivor' Screens as Lone Victor
New releases have a habit of floundering in January, which tends to be one of Hollywood's biggest dumping grounds.
Even this year's big January horror release, which is commonly a sure thing, floundered.
What does tend to do well are the prestige pictures which opened late in the previous year (often in limited release) and expand in the new year, riding awards momentum to solid box-office receipts.
Peter Berg's "Lone Survivor" emerged from limited release last week to rise at the box office.
|To Date
|Lone Survivor
|$38.5 million
|$38.9 million
|$15.1 million
|$317.7 million
|The Wolf of Wall Street
|$9.0 million
|$78.6 million
|The Legend of Hercules
|$8.6 million
|$8.6 million
|American Hustle
|$8.6 million
|$101.6 million
|The Hobbit: The Desolation of Smaug
|$8.1 million
|$242.4 million
|August: Osage County
|$7.3 million
|$7.9 million
|Saving Mr. Banks
|$6.6 million
|$68.9 million
|Paranormal Activity: The Marked Ones
|$6.3 million
|$28.5 million
|Anchorman 2: The Legend Continues
|$6.1 million
|$118.5 million
With a $38 million opening weekend, the Afghanistan-set war movie "Lone Survivor" has effortlessly become one of the most successful movies dealing with this particular subject matter.
If "The Hurt Locker" can win best picture with anemic box-office numbers, does this mean "Lone Survivor" has gold in its future?
In second place, Disney's "Frozen" continued to heat up the charts, grossing $15 million for a $317 million total. That puts it only $50 million away from "Despicable Me 2," which is currently the highest-grossing animated film released in 2013.
In third place, "The Wolf of Wall Street" held on, grossing $9 million for a $78 million total. . Meanwhile, "American Hustle," the other movie about white collar criminals in the top 10, crossed the $100 million mark.
Meanwhile, "The Legend of Hercules" came out as a weakling.
The bottom half of the top 10 this week was led by "The Hobbit: The Desolation of Smaug," which is looking like the lowest grossing Middle-earth movie to date. It appears the film's final gross will be in the neighborhood of $270 million.
Like "Lone Survivor," "August: Osage County" also expanded screens and grossed $7 million.
Right below it, "Saving Mr. Banks" did much better, with $68 million grossed so far.
"Paranormal Activity: The Marked Ones" plummeted 65 percent and fell seven spots since last weekend. It's undoubtedly going to be the lowest grossing film in the franchise, but is it a full-on franchise killer? "Paranormal Activity 5″ is still in the works.


text:
The guys try not to crack under pressure.
The "X-Men" star stops by the office.
Hardly Working: He's Such a McConaughey
Judging someone is not alright, alright, alright.
Hardly Working: This is Basically What It's Like to Invest in Bitcoin
Watch now before it's not worth your time.
Hardly Working: Can You Beat a Duck in a Trivia Game?
Ducks fly together. Humans lose alone.
Hardly Working is NOT fake! See more at collegehumor.com/hardlyworking
Shit got real.
The gang tag-teams with new intern Mick Foley to pin down the perpetrator of this office mystery.
Insulting The Boss With A Punk Rock Video
Down with the man! The little man. The very little man.
Our LIVE SHOW is TONIGHT! Reserve your tickets now or we'll give you the silent treatment!
It's FREE to reserve and only $5 at the door + we can get super drunk together and laugh at how sweaty Streeter gets on stage.
TICKETS HERE - http://newyork.ucbtheatre.com/shows/view/1792
(via collegehumor)
Business as usual.
Hardly Working: Sex, Drugs, and Treen
The hardest questions have the dumbest answer.
If you like our new 3D poster then you'll love seeing us in 3D TONIGHT! Reserve your tickets for free and come hang out with us.
We have a monstrous show with host Streeter Seidell and a load of awesome stand-up comedians. Come see:
Dan Gurewitch, Arthur Meyer, Jermaine Fowler + An all new LIVE Hardly Working. Tickets are free to reserve and only $5 at the door. See you tonight. Drink are on my friend's uncle.
Hardly Working: Dan Does His Own Thing
Sometimes it's good to have a little "me" time.
(Source: College Humor)
Dig up those old Avatar glasses you stole 3 1/2 years ago and check out our new 3D poster!
Better yet, just come to the CollegeHumor Live Show Thursday night and you can see us all in 3D! We have a huge show with host Streeter Seidell. See some of the best stand-up comedy in NYC with:
Dan Gurewitch, Arthur Meyer, Jermaine Fowler +
An all new LIVE Hardly Working.
Tickets are free to reserve and only $5 at the door. We better see you Thursday!
(Source: newyork.ucbtheatre.com)
THE FUTURE IS NOW! This Hardly Working is from 3 years ago and references today, July 14, 2013. What if you could see the future… and it looked like an idiot?


text:
Forbes Special Features
Our ranking of America's top colleges.
Click for full photo gallery: Best Northeast Colleges
Our annual ranking of the top Northeastern colleges in the U.S. Click here for the complete ranking of America's Top Colleges.
Forbes writers have the ability to call out member comments they find particularly interesting. Called-out comments are highlighted across the Forbes network. You'll be notified if your comment is called out.


text:
Your Wednesday morning news & notes includes reaction to Pittsburgh's 4-2 victory, a knockout of a knockout for Wade Belak, and one Canadian getting fed up over the "faux patriotism" behind Jim...
John Glennon's article this morning (linked from the Clarkesville Leaf Chronicle, not sure why it's not at the Tennessean yet) digs into the question of whether Colin Wilson is "NHL ready". At 6' 1", 213 lbs., it's not so much a physical question as a mental/emotional one. Personally, I'm of the opinion that he should probably spend most of next season with Milwaukee, getting a taste of the NHL experience but focusing on adapting to the pro game and schedule. But then again, he might look pretty good centering the Preds' 3rd line...
John Glennon at the Tennessean reports that Preds prospect Colin Wilson was named USA Hockey's College Player of the Year today.
Colin Wilson, the Nashville Predators 1st-round draft pick in the 2008 NHL Entry Draft, met with the media at the Sommet Center today, and made sure to shake hands with one local blogger.
The Predators have announced that 2008 1st-round draft pick Colin Wilson will make an appearance at the Open House taking place Sunday, May 17 at the Sommet Center, from 2-4 p.m. to sign autographs and meet fans.
While Alexander Radulov scored the gold medal-winning goal at the World Championships, many other Nashville Predators made an impact as well.
Colin Wilson brings many valued qualities as a Nashville Predators prospect, but working the catwalk? That's unexpected...
The Nashville Predators have put up a nice page detailing the schedule for each Preds player or prospect participating in the World Championships, which begin Friday in Switzerland. In total, 8 players from the organization (if you include Alexander Radulov for Russia) are involved.
After leading Boston University to the NCAA men's hockey championship, forward Colin Wilson signed a pro contract with the Nashville Predators.
We'll email you a reset link.
If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.
You must be a member of On the Forecheck to participate.
We have our own Community Guidelines at On the Forecheck. You should read them.
You must be a member of On the Forecheck to participate.
We have our own Community Guidelines at On the Forecheck. You should read them.
Choose an available username to complete sign up.
In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.